www.fdanews.com/articles/113607-bioreliance-announces-agreement-with-barr-to-supply-bulk-virus

BioReliance Announces Agreement With Barr to Supply Bulk Virus

January 9, 2009

BioReliance Corporation announced that it has been contracted by Barr Pharmaceuticals, Inc. to supply bulk adenovirus for the manufacture of Duramed Pharmaceuticals, Inc.’s Adenovirus Types 4 and 7 Live Oral Vaccines.
MarketWatch